title: Endobronchial Valves for Endoscopic Lung Volume Reduction: Best Practice Recommendations from Expert Panel on Endoscopic Lung Volume Reduction.
abstract: Endoscopic lung volume reduction (ELVR) is being adopted as a treatment option for carefully selected patients suffering from severe emphysema. ELVR with the one-way endobronchial Zephyr valves (EBV) has been demonstrated to improve pulmonary function, exercise capacity, and quality of life in patients with both heterogeneous and homogenous emphysema without collateral ventilation. In this "expert best practices" review, we will highlight the practical aspects of this therapy. Key selection criteria for ELVR are hyperinflation with a residual volume >175% of predicted, forced expiratory volume <50% of predicted, and a 6-min walking distance >100 m. Patients with repeated infectious complications, severe bronchiectasis, and those with unstable cardiovascular comorbidities should be excluded from EBV treatment. The procedure may be performed with either conscious sedation or general anesthesia and positive pressure mechanical ventilation using a flexible endotracheal tube or a rigid bronchoscope. Chartis and EBV placement should be performed in 1 procedure when possible. The sequence of valve placement should be orchestrated to avoid obstruction and delivery of subsequent valves. If atelectasis has not occurred by 1 month after procedure, evaluate valve position on CT and consider replacing the valves that are not optimally positioned. Pneumothorax is a common complication and typically occurs in the first 2 days following treatment. A management algorithm for pneumothorax has been previously published. Long-term sequelae from EBV therapy do occur but are easily manageable.
authors.affiliation: Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
authors.forename: Dirk-Jan
authors.initials: DJ
authors.lastname: Slebos
authors.forename: Pallav L
authors.initials: PL
authors.lastname: Shah
authors.forename: Felix J F
authors.initials: FJ
authors.lastname: Herth
authors.forename: Arschang
authors.initials: A
authors.lastname: Valipour
mesh_terms: D000287:Administration, Topical; D000768:Anesthesia, General / Q000379:methods; D000779:Anesthetics, Local / Q000627:therapeutic use; D001999:Bronchoscopy / Q000379:methods*; D016292:Procedural Sedation / Q000379:methods; D054810:Deep Sedation / Q000379:methods; D017079:Exercise Tolerance; D005541:Forced Expiratory Volume; D005548:Foreign-Body Migration / Q000601:surgery; D006801:Humans; D021621:Imaging, Three-Dimensional; D008012:Lidocaine / Q000627:therapeutic use; D018579:Patient Selection; D011013:Pneumonectomy / Q000379:methods*; D011030:Pneumothorax / Q000628:therapy; D011183:Postoperative Complications / Q000628:therapy*; D017410:Practice Guidelines as Topic; D019919:Prosthesis Implantation / Q000379:methods*; D011656:Pulmonary Emphysema / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000601:surgery*; D012123:Pulmonary Ventilation / Q000502:physiology*; D013902:Radiography, Thoracic; D012720:Severity of Illness Index; D014057:Tomography, X-Ray Computed
chemical_list: D000779:Anesthetics, Local; D008012:Lidocaine